On October 25, 2019 SFA Therapeutics, Inc. reported that Dr. Ira Spector, company CEO, will report on updates in the company’s clinical development plans for several new therapeutic agents they have derived from the human microbiome (Press release, SFA Therapeutics, OCT 25, 2019, View Source [SID1234542538]). The presentation will be delivered as part of the Microbiome R&D and Business Collaboration Forum on October 29th at 5:45PM at the Paradise Point Resort & Spa in San Diego, CA.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!